Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AAA Graft Pre-Clinical Workshop Input Could Be Included In ISO Standards

This article was originally published in The Gray Sheet

Executive Summary

The International Organization for Standards (ISO) is considering pre-clinical testing standards for abdominal aortic anyeursm (AAA) endovascular grafts based on types of device failure identified in clinical studies and postmarket surveillance data.

You may also be interested in...



AAA Workshop Participants De-Emphasize Preclinical Animal Studies

Biological response to new and modified abdominal aortic aneurysm devices should be tested in preclinical animal studies, participants agreed at an FDA workshop on AAA endografts July 28-29

AAA Workshop Participants De-Emphasize Preclinical Animal Studies

Biological response to new and modified abdominal aortic aneurysm devices should be tested in preclinical animal studies, participants agreed at an FDA workshop on AAA endografts July 28-29

FDA Relaxes AAA Panel Meeting Criteria; Thoracic Endograft Approvals Lag

Abdominal aortic aneurysm endograft applications will no longer require advisory panel review, unless new issues arise in the course of FDA's premarket evaluation

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015234

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel